Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.

BACKGROUND & AIMS Severe forms of inflammatory bowel disease (IBD) that develop in very young children can be caused by variants in a single gene. We performed whole-exome sequence (WES) analysis to identify genetic factors that might cause granulomatous colitis and severe perianal disease, with recurrent bacterial and viral infections, in an infant of consanguineous parents. METHODS We performed targeted WES analysis of DNA collected from the patient and her parents. We validated our findings by a similar analysis of DNA from 150 patients with very-early-onset IBD not associated with known genetic factors analyzed in Toronto, Oxford, and Munich. We compared gene expression signatures in inflamed vs noninflamed intestinal and rectal tissues collected from patients with treatment-resistant Crohn's disease who participated in a trial of ustekinumab. We performed functional studies of identified variants in primary cells from patients and cell culture. RESULTS We identified a homozygous variant in the tripartite motif containing 22 gene (TRIM22) of the patient, as well as in 2 patients with a disease similar phenotype. Functional studies showed that the variant disrupted the ability of TRIM22 to regulate nucleotide binding oligomerization domain containing 2 (NOD2)-dependent activation of interferon-beta signaling and nuclear factor-κB. Computational studies demonstrated a correlation between the TRIM22-NOD2 network and signaling pathways and genetic factors associated very early onset and adult-onset IBD. TRIM22 is also associated with antiviral and mycobacterial effectors and markers of inflammation, such as fecal calprotectin, C-reactive protein, and Crohn's disease activity index scores. CONCLUSIONS In WES and targeted exome sequence analyses of an infant with severe IBD characterized by granulomatous colitis and severe perianal disease, we identified a homozygous variant of TRIM22 that affects the ability of its product to regulate NOD2. Combined computational and functional studies showed that the TRIM22-NOD2 network regulates antiviral and antibacterial signaling pathways that contribute to inflammation. Further study of this network could lead to new disease markers and therapeutic targets for patients with very early and adult-onset IBD.

[1]  U. Gullberg,et al.  Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow. , 2007, Leukemia research.

[2]  H. Drummond,et al.  Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis , 2009, The American Journal of Gastroenterology.

[3]  A. Schäffer,et al.  Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.

[4]  Judy H. Cho,et al.  Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis. , 2011, Gastroenterology.

[5]  E. Schadt,et al.  Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. , 2014, Gastroenterology.

[6]  Jenna N. Kelly,et al.  In Silico Analysis of Functional Single Nucleotide Polymorphisms in the Human TRIM22 Gene , 2014, PloS one.

[7]  W. Sandborn,et al.  Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. , 2012, The New England journal of medicine.

[8]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[9]  Tomohiro Watanabe,et al.  NOD2, an Intracellular Innate Immune Sensor Involved in Host Defense and Crohn's Disease , 2011, Mucosal Immunology.

[10]  M. Peters,et al.  Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.

[11]  A. Kajaste-Rudnitski,et al.  TRIM22 Inhibits Influenza A Virus Infection by Targeting the Viral Nucleoprotein for Degradation , 2013, Journal of Virology.

[12]  M. Silverberg,et al.  Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. , 2014, Gastroenterology.

[13]  R. Higgs,et al.  Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? , 2011, Nature Reviews Immunology.

[14]  M. Silverberg,et al.  IL-10R Polymorphisms Are Associated with Very-early-onset Ulcerative Colitis , 2013, Inflammatory bowel diseases.

[15]  Jun Zhu,et al.  Increasing the Power to Detect Causal Associations by Combining Genotypic and Expression Data in Segregating Populations , 2007, PLoS Comput. Biol..

[16]  A. Fischer,et al.  Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes. , 2013, Blood.

[17]  C. Klein,et al.  The diagnostic approach to monogenic very early onset inflammatory bowel disease. , 2014, Gastroenterology.

[18]  N. Warner,et al.  Reduced sodium/proton exchanger NHE3 activity causes congenital sodium diarrhea. , 2015, Human molecular genetics.

[19]  K. Iwai,et al.  Generation and physiological roles of linear ubiquitin chains , 2012, BMC Biology.

[20]  Sophie J Deharvengt,et al.  Mutations in Plasmalemma Vesicle Associated Protein Result in Sieving Protein-Losing Enteropathy Characterized by Hypoproteinemia, Hypoalbuminemia, and Hypertriglyceridemia , 2015, Cellular and molecular gastroenterology and hepatology.

[21]  Bo Gao,et al.  Identification of TRIM22 as a RING finger E3 ubiquitin ligase. , 2008, Biochemical and biophysical research communications.

[22]  S. Melgar,et al.  Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis , 2013, Nature Immunology.

[23]  Manolis Kellis,et al.  Common Genetic Variants Modulate Pathogen-Sensing Responses in Human Dendritic Cells , 2014, Science.

[24]  N. Mailand,et al.  Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling , 2013, EMBO molecular medicine.

[25]  T. Murdoch,et al.  Biomarkers as potential treatment targets in inflammatory bowel disease: A systematic review. , 2015, Canadian journal of gastroenterology & hepatology.

[26]  Wei Xu,et al.  Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-κB activator. , 2011, Biochemical and biophysical research communications.

[27]  Tao Xie,et al.  Inferring causal genomic alterations in breast cancer using gene expression data , 2011, BMC Systems Biology.

[28]  ZhangBin,et al.  Defining clusters from a hierarchical cluster tree , 2008 .

[29]  A. Vazquez,et al.  MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors , 2012, BMC Biology.

[30]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Barabasi,et al.  Hierarchical Organization of Modularity in Metabolic Networks , 2002, Science.

[32]  D. Philpott,et al.  NOD proteins: regulators of inflammation in health and disease , 2013, Nature Reviews Immunology.

[33]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[34]  Xia Yang,et al.  Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. , 2010, Genome research.

[35]  J. Casanova,et al.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. , 2014, Seminars in immunology.

[36]  A. Fischer,et al.  Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG. , 2011, Blood.

[37]  J. Zhu,et al.  An integrative genomics approach to the reconstruction of gene networks in segregating populations , 2004, Cytogenetic and Genome Research.

[38]  F. Bushman,et al.  The Interferon Response Inhibits HIV Particle Production by Induction of TRIM22 , 2008, PLoS pathogens.

[39]  L. Cantley,et al.  Coordinated Regulation of Toll-Like Receptor and NOD2 Signaling by K63-Linked Polyubiquitin Chains , 2007, Molecular and Cellular Biology.

[40]  M. Silverberg,et al.  Higher Activity of the Inducible Nitric Oxide Synthase Contributes to Very Early Onset Inflammatory Bowel Disease , 2014, Clinical and Translational Gastroenterology.

[41]  Kaoru Tominaga,et al.  Activation of innate immune antiviral response by NOD2 , 2009, Nature Immunology.

[42]  John D. Storey,et al.  Mapping the Genetic Architecture of Gene Expression in Human Liver , 2008, PLoS biology.

[43]  J. York,et al.  Bayesian Graphical Models for Discrete Data , 1995 .

[44]  G. Meroni,et al.  TRIM27 Negatively Regulates NOD2 by Ubiquitination and Proteasomal Degradation , 2012, PloS one.

[45]  Jenna N. Kelly,et al.  TRIM22: A Diverse and Dynamic Antiviral Protein , 2012, Molecular biology international.

[46]  Keun Woo Lee,et al.  TRIM32 Protein Sensitizes Cells to Tumor Necrosis Factor (TNFα)-induced Apoptosis via Its RING Domain-dependent E3 Ligase Activity against X-linked Inhibitor of Apoptosis (XIAP)* , 2011, The Journal of Biological Chemistry.

[47]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[48]  N. Warner,et al.  The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation. , 2011, Trends in immunology.

[49]  Yudong D. He,et al.  Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers , 2012, Molecular systems biology.

[50]  G. Schwarz.  Estimating the Dimension of a Model , 1978 .

[51]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[52]  J. B. Garrison,et al.  XIAP mediates NOD signaling via interaction with RIP2 , 2009, Proceedings of the National Academy of Sciences.

[53]  Rachel B. Brem,et al.  Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks , 2008, Nature Genetics.

[54]  Michael Emerman,et al.  Discordant Evolution of the Adjacent Antiretroviral Genes TRIM22 and TRIM5 in Mammals , 2007, PLoS pathogens.

[55]  G. Greenberg,et al.  Ustekinumab induction and maintenance therapy in refractory Crohn's disease. , 2012, The New England journal of medicine.

[56]  S. Latour,et al.  XIAP deficiency syndrome in humans. , 2015, Seminars in cell & developmental biology.

[57]  P. Rosenstiel,et al.  XIAP variants in male Crohn's disease , 2014, Gut.

[58]  Timothy L. Tickle,et al.  Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. , 2014, The Journal of clinical investigation.

[59]  Judy H. Cho,et al.  [Letters to Nature] , 1975, Nature.

[60]  Brian J. Smith,et al.  The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[61]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[62]  Yong-Zi Chen,et al.  Prediction of Ubiquitination Sites by Using the Composition of k-Spaced Amino Acid Pairs , 2011, PloS one.

[63]  S. Akira,et al.  Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections. , 2011, Cell host & microbe.

[64]  Judy H. Cho,et al.  NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2 , 2011, Gut.

[65]  I. Verma,et al.  NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.

[66]  R. Schwarzenbacher,et al.  Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation , 2012, Innate immunity.

[67]  C. Geczy,et al.  Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease , 2007, Scandinavian journal of gastroenterology.

[68]  L. Walter,et al.  Different subcellular localisations of TRIM22 suggest species-specific function , 2009, Immunogenetics.

[69]  S. Akira,et al.  Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins , 2011, EMBO molecular medicine.

[70]  L. Papon,et al.  TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus. , 2009, The Journal of general virology.